bradykinin, sar-(d-phe(8))des-arg(9) has been researched along with halothane in 1 studies
Studies (bradykinin, sar-(d-phe(8))des-arg(9)) | Trials (bradykinin, sar-(d-phe(8))des-arg(9)) | Recent Studies (post-2010) (bradykinin, sar-(d-phe(8))des-arg(9)) | Studies (halothane) | Trials (halothane) | Recent Studies (post-2010) (halothane) |
---|---|---|---|---|---|
18 | 0 | 1 | 14,369 | 884 | 235 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Audet, R; Drapeau, G; Marceau, F; Rioux, F | 1 |
1 other study(ies) available for bradykinin, sar-(d-phe(8))des-arg(9) and halothane
Article | Year |
---|---|
Cardiovascular effects of Sar-[D-Phe8]des-Arg9-bradykinin, a metabolically protected agonist of B1 receptor for kinins, in the anesthetized rabbit pretreated with a sublethal dose of bacterial lipopolysaccharide.
Topics: Anesthesia; Animals; Bradykinin; Female; Halothane; Hemodynamics; Lipopolysaccharides; Male; Nitric Oxide; Rabbits; Receptor, Bradykinin B1; Receptors, Bradykinin | 1997 |